Foslevodopa/Foscarbidopa

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameFoslevodopa/Foscarbidopa
Drug Alias NameLevodopa/Carbidopa prodrugProduodopaVYALEVVyalevProduodopa +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine receptors agonistsDOPA decarboxylase inhibitors
TargetsDopamine receptorsAromatic-L-amino-acid decarboxylase
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsParkinson Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritoryBelgiumRomaniaCyprus
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumBulgaria +[33] 
CombinationsYes
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesAbbvie SaAbbvie DooAbbvie Bv +[15] 
Inactive CompaniesN/A
Active IndicationsParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG